289 related articles for article (PubMed ID: 19329323)
1. Design and synthesis of 3-phenyltetrahydronaphthalenic derivatives as new selective MT2 melatoninergic ligands. Part II.
Durieux S; Chanu A; Bochu C; Audinot V; Coumailleau S; Boutin JA; Delagrange P; Caignard DH; Bennejean C; Renard P; Lesieur D; Berthelot P; Yous S
Bioorg Med Chem; 2009 Apr; 17(8):2963-74. PubMed ID: 19329323
[TBL] [Abstract][Full Text] [Related]
2. Synthesis of 3-phenylnaphthalenic derivatives as new selective MT(2) melatoninergic ligands.
Poissonnier-Durieux S; Ettaoussi M; Pérès B; Boutin JA; Audinot V; Bennejean C; Delagrange P; Caignard DH; Renard P; Berthelot P; Lesieur D; Yous S
Bioorg Med Chem; 2008 Sep; 16(18):8339-48. PubMed ID: 18778943
[TBL] [Abstract][Full Text] [Related]
3. Synthesis and pharmacological evaluation of 1,2,3,4-tetrahydropyrazino[1,2-a]indole and 2-[(phenylmethylamino)methyl]-1H-indole analogues as novel melatoninergic ligands.
Markl C; Attia MI; Julius J; Sethi S; Witt-Enderby PA; Zlotos DP
Bioorg Med Chem; 2009 Jul; 17(13):4583-94. PubMed ID: 19473848
[TBL] [Abstract][Full Text] [Related]
4. Design and synthesis of 3-phenyl tetrahydronaphthalenic derivatives as new selective MT2 melatoninergic ligands.
Yous S; Durieux-Poissonnier S; Lipka-Belloli E; Guelzim H; Bochu C; Audinot V; Boutin JA; Delagrange P; Bennejean C; Renard P; Lesieur D
Bioorg Med Chem; 2003 Mar; 11(5):753-9. PubMed ID: 12538005
[TBL] [Abstract][Full Text] [Related]
5. Design, synthesis, and pharmacological effects of structurally simple ligands for MT(1) and MT(2) melatonin receptors.
Carocci A; Catalano A; Lovece A; Lentini G; Duranti A; Lucini V; Pannacci M; Scaglione F; Franchini C
Bioorg Med Chem; 2010 Sep; 18(17):6496-511. PubMed ID: 20674373
[TBL] [Abstract][Full Text] [Related]
6. Synthesis and pharmacological evaluation of pentacyclic 6a,7-dihydrodiindole and 2,3-dihydrodiindole derivatives as novel melatoninergic ligands.
Attia MI; Witt-Enderby PA; Julius J
Bioorg Med Chem; 2008 Aug; 16(16):7654-61. PubMed ID: 18657980
[TBL] [Abstract][Full Text] [Related]
7. Design and synthesis of N-(3,3-diphenylpropenyl)alkanamides as a novel class of high-affinity MT2-selective melatonin receptor ligands.
Bedini A; Spadoni G; Gatti G; Lucarini S; Tarzia G; Rivara S; Lorenzi S; Lodola A; Mor M; Lucini V; Pannacci M; Scaglione F
J Med Chem; 2006 Dec; 49(25):7393-403. PubMed ID: 17149869
[TBL] [Abstract][Full Text] [Related]
8. Synthesis of substituted N-[3-(3-methoxyphenyl)propyl] amides as highly potent MT(2)-selective melatonin ligands.
Hu Y; Ho MK; Chan KH; New DC; Wong YH
Bioorg Med Chem Lett; 2010 Apr; 20(8):2582-5. PubMed ID: 20227878
[TBL] [Abstract][Full Text] [Related]
9. N-(substituted-anilinoethyl)amides: design, synthesis, and pharmacological characterization of a new class of melatonin receptor ligands.
Rivara S; Lodola A; Mor M; Bedini A; Spadoni G; Lucini V; Pannacci M; Fraschini F; Scaglione F; Sanchez RO; Gobbi G; Tarzia G
J Med Chem; 2007 Dec; 50(26):6618-26. PubMed ID: 18052314
[TBL] [Abstract][Full Text] [Related]
10. Preparation and pharmacological evaluation of a novel series of 2-(phenylthio)benzo[b]thiophenes as selective MT2 receptor ligands.
Mésangeau C; Fraise M; Delagrange P; Caignard DH; Boutin JA; Berthelot P; Yous S
Eur J Med Chem; 2011 May; 46(5):1835-40. PubMed ID: 21392858
[TBL] [Abstract][Full Text] [Related]
11. Synthesis and functional characterization of substituted isoquinolinones as MT2-selective melatoninergic ligands.
Hu Y; Chan KH; He X; Ho MK; Wong YH
PLoS One; 2014; 9(12):e113638. PubMed ID: 25479338
[TBL] [Abstract][Full Text] [Related]
12. N-Acetyl-5-arylalkoxytryptamine analogs: probing the melatonin receptors for MT(1) -selectivity.
Markl C; Clafshenkel WP; Attia MI; Sethi S; Witt-Enderby PA; Zlotos DP
Arch Pharm (Weinheim); 2011 Oct; 344(10):666-74. PubMed ID: 21887801
[TBL] [Abstract][Full Text] [Related]
13. New melatonin (MT1/MT2) ligands: design and synthesis of (8,9-dihydro-7H-furo[3,2-f]chromen-1-yl) derivatives.
Landagaray E; Ettaoussi M; Leclerc V; Traoré B; Perez V; Nosjean O; Boutin JA; Caignard DH; Delagrange P; Berthelot P; Yous S
Bioorg Med Chem; 2014 Feb; 22(3):986-96. PubMed ID: 24417958
[TBL] [Abstract][Full Text] [Related]
14. Synthesis and structure-activity relationship of novel benzoxazole derivatives as melatonin receptor agonists.
Sun LQ; Chen J; Bruce M; Deskus JA; Epperson JR; Takaki K; Johnson G; Iben L; Mahle CD; Ryan E; Xu C
Bioorg Med Chem Lett; 2004 Jul; 14(14):3799-802. PubMed ID: 15203165
[TBL] [Abstract][Full Text] [Related]
15. Design, synthesis and melatoninergic potency of new N-acyl 8,9-dihydro-4-methoxy-7H-2-benzo[de]quinolinalkanamines.
Tsotinis A; Eleutheriades A; Hough KA; Davidson K; Sugden D
Bioorg Chem; 2007 Apr; 35(2):189-204. PubMed ID: 17223160
[TBL] [Abstract][Full Text] [Related]
16. Analysis of structure-activity relationships for MT2 selective antagonists by melatonin MT1 and MT2 receptor models.
Rivara S; Lorenzi S; Mor M; Plazzi PV; Spadoni G; Bedini A; Tarzia G
J Med Chem; 2005 Jun; 48(12):4049-60. PubMed ID: 15943478
[TBL] [Abstract][Full Text] [Related]
17. Molecular cloning and pharmacological characterization of rat melatonin MT1 and MT2 receptors.
Audinot V; Bonnaud A; Grandcolas L; Rodriguez M; Nagel N; Galizzi JP; Balik A; Messager S; Hazlerigg DG; Barrett P; Delagrange P; Boutin JA
Biochem Pharmacol; 2008 May; 75(10):2007-19. PubMed ID: 18384758
[TBL] [Abstract][Full Text] [Related]
18. Tricyclic alkylamides as melatonin receptor ligands with antagonist or inverse agonist activity.
Lucini V; Pannacci M; Scaglione F; Fraschini F; Rivara S; Mor M; Bordi F; Plazzi PV; Spadoni G; Bedini A; Piersanti G; Diamantini G; Tarzia G
J Med Chem; 2004 Aug; 47(17):4202-12. PubMed ID: 15293992
[TBL] [Abstract][Full Text] [Related]
19. Melatonergic ligands: Design, synthesis and pharmacological evaluation of novel series of naphthofuranic derivatives.
Landagaray E; Ettaoussi M; Duroux R; Boutin JA; Caignard DH; Delagrange P; Melnyk P; Berthelot P; Yous S
Eur J Med Chem; 2016 Feb; 109():360-70. PubMed ID: 26820449
[TBL] [Abstract][Full Text] [Related]
20. 2-[(2,3-dihydro-1H-indol-1-yl)methyl]melatonin analogues: a novel class of MT2-selective melatonin receptor antagonists.
Zlotos DP; Attia MI; Julius J; Sethi S; Witt-Enderby PA
J Med Chem; 2009 Feb; 52(3):826-33. PubMed ID: 19193160
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]